Home » Posts tagged with "Celltrion"

FDA Gives Approval to Knockoff for Rheumatoid

The U.S. Food and Drug Administration has cleared the sale of a knockoff of Remicade the Johnson & Johnson anti-inflammatory drug, the second treatment in the fledgling market in the U.S. for less expensive copies of biotechnology high-priced drugs. The FDA announced this week it had approved Inflectra a drug developed by Celltrion Inc based in South Korea and licensed to Pfizer, for the treatment of inflammatory bowel diseases, rheumatoid arthritis and other types of conditions. Inflectra is what the drug industry and regulators call a biosimilar... 
© 2006-2017 Rincon Hill News.